Jones Financial Companies Portfolio holdings
AUM
$132B
This Quarter Return
+3.51%
1 Year Return
+13.14%
3 Year Return
+40.08%
5 Year Return
+56.47%
10 Year Return
+87.84%
AUM
$10.3B
AUM Growth
+$10.3B
(+11%)
Cap. Flow
+$688M
Cap. Flow
% of AUM
6.66%
Top 10 Holdings %
Top 10 Hldgs %
83.6%
Holding
917
New
135
Increased
231
Reduced
161
Closed
205
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
$202M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$178M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
$47.7M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
$44M |
| 5 |
Vanguard Value ETF
VTV
|
$33.8M |
Top Sells
| 1 |
Vanguard Intermediate-Term Bond ETF
BIV
|
$2.12M |
| 2 |
Vodafone
VOD
|
$2.06M |
| 3 |
Exxon Mobil
XOM
|
$775K |
| 4 |
Bristol-Myers Squibb
BMY
|
$748K |
| 5 |
iShares Russell Mid-Cap ETF
IWR
|
$672K |
Sector Composition
| 1 | Healthcare | 0.67% |
| 2 | Industrials | 0.59% |
| 3 | Consumer Staples | 0.57% |
| 4 | Financials | 0.56% |
| 5 | Energy | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Abbott
ABT
$231B
| $1.69M | 0.02% |
50,771
+8,749
| +21% | +$290K |
|
127
Sysco
SYY
$38.5B
| $1.57M | 0.02% |
49,458
-6,573
| -12% | -$209K |
|
128
Phillips 66
PSX
$54B
| $1.54M | 0.01% |
26,708
-851
| -3% | -$49.2K |
|
|
POT
129
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.49M | 0.01% |
47,542
-1,326
| -3% | -$41.5K |
|
130
Realty Income
O
$52.8B
| $1.38M | 0.01% |
34,754
-3,913
| -10% | -$156K |
|
131
Intel
INTC
$106B
| $1.38M | 0.01% |
60,067
+6,968
| +13% | +$160K |
|
|
SE
132
DELISTED
Spectra Energy Corp Wi
SE
| $1.37M | 0.01% |
39,978
+357
| +0.9% | +$12.2K |
|
133
Verizon
VZ
$185B
| $1.32M | 0.01% |
28,261
-1,560
| -5% | -$72.9K |
|
134
Altria Group
MO
$113B
| $1.3M | 0.01% |
37,962
-8,774
| -19% | -$301K |
|
135
Parker-Hannifin
PH
$96.2B
| $1.26M | 0.01% |
11,627
+1,100
| +10% | +$120K |
|
136
Capital One
COF
$145B
| $1.25M | 0.01% |
18,155
+8,087
| +80% | +$556K |
|
137
Bank of America
BAC
$373B
| $1.23M | 0.01% |
88,921
+29,139
| +49% | +$402K |
|
138
AbbVie
ABBV
$374B
| $1.2M | 0.01% |
26,852
+3,505
| +15% | +$157K |
|
139
Eversource Energy
ES
$23.8B
| $1.2M | 0.01% |
28,962
+8,714
| +43% | +$360K |
|
140
Invesco
IVZ
$9.76B
| $1.17M | 0.01% |
36,725
+199
| +0.5% | +$6.35K |
|
141
Boeing
BA
$179B
| $1.13M | 0.01% |
9,584
+1,095
| +13% | +$129K |
|
142
Morgan Stanley
MS
$240B
| $1.12M | 0.01% |
41,696
-4,002
| -9% | -$108K |
|
143
Baxter International
BAX
$12.7B
| $1.12M | 0.01% |
17,078
+6,265
| +58% | +$412K |
|
144
Thomson Reuters
TRI
$80B
| $1.11M | 0.01% |
31,815
+5,849
| +23% | +$205K |
|
145
Nike
NKE
$110B
| $1.09M | 0.01% |
15,013
-5,235
| -26% | -$380K |
|
146
GSK
GSK
$78.5B
| $1.07M | 0.01% |
21,415
-2,161
| -9% | -$108K |
|
147
Teva Pharmaceuticals
TEVA
$21.5B
| $1.05M | 0.01% |
27,769
+994
| +4% | +$37.5K |
|
|
STJ
148
DELISTED
St Jude Medical
STJ
| $1.02M | 0.01% |
18,972
-197
| -1% | -$10.6K |
|
149
Colgate-Palmolive
CL
$67.9B
| $1.01M | 0.01% |
17,102
+6,137
| +56% | +$364K |
|
|
150
Bristol-Myers Squibb
BMY
$96B
| $1.01M | 0.01% |
21,845
-16,157
| -43% | -$748K |
|